Glaxo whistleblowers to pocket $250m for coming forward

Stat of the day: $250m. That's how much money four employees will share after giving evidence that helped US authorities build a case against GlaxoSmithKline's sales practices.

by Michael Northcott
Last Updated: 09 Oct 2013

GSK has been fined a record $3bn for mis-promoting a child anti-depressant drug by paying for medics to enjoy deep-sea fishing, hot air balloon rides and golfing days in Hawaii. The company hoped the practice would mean doctors would prescribe more of their drugs.

Former GSK employees Blair Hamrick, Thomas Gerahty, Matthew Burke and Greg Thorpe will receive the money as part of a centuries old US law which affords whistleblowers a piece of the pie when the proceeds of a fraud are recovered but authorities.

As you might expect, none of the four still works for GSK. And it’s no surprise GSK might be unhappy with them: US prosecutors reckon their evidence helped secure around a third of the $3bn fine. Ouch!

Find this article useful?

Get more great articles like this in your inbox every lunchtime

Leadership lessons from Jürgen Klopp

The Liverpool manager exemplifies ‘the long win’, based not on results but on clarity of...

How to get a grip on stress

Once a zebra escapes the lion's jaws, it goes back to grazing peacefully. There's a...

A leadership thought: Treat your colleagues like customers

One minute briefing: Create a platform where others can see their success, says AVEVA CEO...

The ignominious death of Gordon Gekko

Profit at all costs is a defunct philosophy, and purpose a corporate superpower, argues this...

Gender bias is kept alive by those who think it is dead

Research: Greater representation of women does not automatically lead to equal treatment.

What I learned leading a Syrian bank through a civil war

Louai Al Roumani was CFO of Syria's largest private retail bank when the conflict broke...